- Home
- JCTC vs SNSE Comparison
JCTC vs SNSE Comparison
Compare JCTC & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JCTC
- SNSE
- Stock Information
- Founded
- JCTC 1953
- SNSE 2005
- Country
- JCTC United States
- SNSE United States
- Employees
- JCTC N/A
- SNSE N/A
- Industry
- JCTC
- SNSE Biotechnology: Pharmaceutical Preparations
- Sector
- JCTC
- SNSE Health Care
- Exchange
- JCTC NYSE
- SNSE Nasdaq
- Market Cap
- JCTC 14.7M
- SNSE 12.5M
- IPO Year
- JCTC 1996
- SNSE 2021
- Fundamental
- Price
- JCTC $4.20
- SNSE $0.29
- Analyst Decision
- JCTC
- SNSE Strong Buy
- Analyst Count
- JCTC 0
- SNSE 4
- Target Price
- JCTC N/A
- SNSE $4.25
- AVG Volume (30 Days)
- JCTC 7.3K
- SNSE 8.2M
- Earning Date
- JCTC 04-14-2025
- SNSE 05-08-2025
- Dividend Yield
- JCTC N/A
- SNSE N/A
- EPS Growth
- JCTC N/A
- SNSE N/A
- EPS
- JCTC N/A
- SNSE N/A
- Revenue
- JCTC $46,606,336.00
- SNSE N/A
- Revenue This Year
- JCTC N/A
- SNSE N/A
- Revenue Next Year
- JCTC N/A
- SNSE N/A
- P/E Ratio
- JCTC N/A
- SNSE N/A
- Revenue Growth
- JCTC N/A
- SNSE N/A
- 52 Week Low
- JCTC $3.86
- SNSE $0.25
- 52 Week High
- JCTC $5.69
- SNSE $1.94
- Technical
- Relative Strength Index (RSI)
- JCTC N/A
- SNSE 31.30
- Support Level
- JCTC N/A
- SNSE $0.29
- Resistance Level
- JCTC N/A
- SNSE $0.76
- Average True Range (ATR)
- JCTC 0.00
- SNSE 0.08
- MACD
- JCTC 0.00
- SNSE -0.02
- Stochastic Oscillator
- JCTC 0.00
- SNSE 7.59
About JCTC JEWETT-CAMERON TRADING CO
Jewett-Cameron Trading Co Ltd through its subsidiaries engages in the wholesale distribution of a variety of specialty wood products. Its operating segments include, The Industrial wood products segment is engaged in the processing and distribution of industrial wood products. The Pet Fencing and Other segment, which is the key revenue driver, operates as a wholesaler of wood products and a manufacturer and distributor of specialty metal products. The Seed processing and sales segment processes and distributes agricultural seed and Corporate and administrative. The company predominantly operates in the United States and also has a presence in Canada, Latin America, Europe and Asia Pacific, and other regions.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.